David Dodds
Geen lopende functies
Profiel
Dr. Dodds has held senior and executive management positions in Sepracor, Schering-Plough, and Bristol-Meyers Squibb.
He has a record of successfully bringing together scientific disciplines in project teams that have created new, commercially successful process technologies.
His industrial experience includes organic synthesis, biotechnology, biocatalysis, natural product fermentation, and downstream processing.
Dr. Dodds obtained his Ph.D.
in synthetic organic chemistry under Prof.
Bryan Jones at the University of Toronto in 1984.
He was awarded a Medical Research Council of Canada post-doctoral fellowship, which he pursued in molecular biology with Prof.
Marvin Caruthers at the University of Colorado, Boulder.
Eerdere bekende functies van David Dodds
| Bedrijven | Functie | Einde |
|---|---|---|
Ventana Capital Management LLC
 Ventana Capital Management LLC Investment ManagersFinance Ventana Capital Management LLC (Ventana Capital) is a venture capital firm founded in 1984 by Tom O. Gephart. The firm is headquartered in Rancho Santa Margarita, California. | Corporate Officer/Principal | 31-12-2008 |
Schering-Plough Biopharma
 Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | Corporate Officer/Principal | - |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | - |
Opleiding van David Dodds
| University of Toronto | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Health Technology |
Ventana Capital Management LLC
Ventana Capital Management LLC Investment ManagersFinance Ventana Capital Management LLC (Ventana Capital) is a venture capital firm founded in 1984 by Tom O. Gephart. The firm is headquartered in Rancho Santa Margarita, California. | Finance |
Schering-Plough Biopharma
Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | Commercial Services |
